These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 22893246)

  • 21. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial reverse remodeling: how far can we rewind?
    Rodrigues PG; Leite-Moreira AF; Falcão-Pires I
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1402-22. PubMed ID: 26993225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of adiponectin and adipolin as anti-inflammatory adipokines in the formation of macrophage foam cells and their association with cardiovascular diseases.
    Sargolzaei J; Chamani E; Kazemi T; Fallah S; Soori H
    Clin Biochem; 2018 Apr; 54():1-10. PubMed ID: 29452073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Adipokines in Cardiovascular Disease.
    Lau WB; Ohashi K; Wang Y; Ogawa H; Murohara T; Ma XL; Ouchi N
    Circ J; 2017 Jun; 81(7):920-928. PubMed ID: 28603178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eplerenone-mediated regression of electrical activation delays and myocardial fibrosis in heart failure.
    J Cardiovasc Electrophysiol; 2014 May; 25(5):556-577. PubMed ID: 24612029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
    Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the Relationship between Adipokines and β-cell Failure in Type 2 Diabetes Mellitus.
    Sun Q; Liang XC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):601-606. PubMed ID: 27825421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Between Inflammation and Autophagy: The Role of Leptin-Adiponectin Axis in Cardiac Remodeling.
    Kamareddine L; Ghantous CM; Allouch S; Al-Ashmar SA; Anlar G; Kannan S; Djouhri L; Korashy HM; Agouni A; Zeidan A
    J Inflamm Res; 2021; 14():5349-5365. PubMed ID: 34703273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular matrix remodeling in hypertensive heart disease.
    Shirwany A; Weber KT
    J Am Coll Cardiol; 2006 Jul; 48(1):97-8. PubMed ID: 16814654
    [No Abstract]   [Full Text] [Related]  

  • 30. Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk.
    Landecho MF; Tuero C; Valentí V; Bilbao I; de la Higuera M; Frühbeck G
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31694146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives.
    Christodoulatos GS; Spyrou N; Kadillari J; Psallida S; Dalamaga M
    Curr Obes Rep; 2019 Dec; 8(4):413-433. PubMed ID: 31637624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From risk factors to structural heart disease: the role of inflammation.
    Kalogeropoulos AP; Georgiopoulou VV; Butler J
    Heart Fail Clin; 2012 Jan; 8(1):113-23. PubMed ID: 22108731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adipokines in neurovascular diseases.
    Opatrilova R; Caprnda M; Kubatka P; Valentova V; Uramova S; Nosal V; Gaspar L; Zachar L; Mozos I; Petrovic D; Dragasek J; Filipova S; Büsselberg D; Zulli A; Rodrigo L; Kruzliak P; Krasnik V
    Biomed Pharmacother; 2018 Feb; 98():424-432. PubMed ID: 29278852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.
    Rajesh Y; Sarkar D
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adiponectin actions in the cardiovascular system.
    Hopkins TA; Ouchi N; Shibata R; Walsh K
    Cardiovasc Res; 2007 Apr; 74(1):11-8. PubMed ID: 17140553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipokines as mediators of endothelial function and atherosclerosis.
    Ntaios G; Gatselis NK; Makaritsis K; Dalekos GN
    Atherosclerosis; 2013 Apr; 227(2):216-21. PubMed ID: 23332774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of adipokines in cardiovascular disease.
    Shibata R; Ouchi N; Ohashi K; Murohara T
    J Cardiol; 2017 Oct; 70(4):329-334. PubMed ID: 28325521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress.
    Veeraveedu PT; Sanada S; Okuda K; Fu HY; Matsuzaki T; Araki R; Yamato M; Yasuda K; Sakata Y; Yoshimoto T; Minamino T
    Biochem Pharmacol; 2017 Aug; 138():73-80. PubMed ID: 28450225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure.
    Brown RD; Ambler SK; Mitchell MD; Long CS
    Annu Rev Pharmacol Toxicol; 2005; 45():657-87. PubMed ID: 15822192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifaceted approach to analyzing the pathogenesis of cardiovascular disease.
    Sano M
    Circ J; 2012; 76(11):2521-9. PubMed ID: 23037324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.